Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022?

Hepatol Commun. 2023 May 15;7(6):e0117. doi: 10.1097/HC9.0000000000000117. eCollection 2023 Jun 1.

Authors

Jeffrey Sum Lung Wong¹, Roland Leung¹, Tan To Cheung², Thomas Yau¹

Affiliations

¹ Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
² Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.

No abstract available

MeSH terms

Antineoplastic Agents* / therapeutic use
Carcinoma, Hepatocellular* / drug therapy
Humans
Liver Neoplasms* / drug therapy

Substances

Antineoplastic Agents